Traditional chemotherapy and radiation therapy may also benefit from a combination of glycosylation-targeting approaches, as demonstrated by the inhibition of GALNT6 [49] and GALNT14 [48] expression in ovarian cancer. This evidence concerns the gene GALNT6 and ovarian cancer.